Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction–Associated Steatotic Liver Disease ( <scp>MASLD</scp> )

The prevalence of significant fibrosis and the effect of GRS were similar in lean and nonlean MASLD, highlighting that lean MASLD patients may have a comparable risk to overweight and obese MASLD.

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2025-10-28
DOI
https://doi.org/10.1111/apt.70433
Citations
5
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
6.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction–Associated Steatotic Liver Disease ( MASLD )

Egbert Madamba, Sadhu Lokanadham, Daniel Q. Huang, Luis Antonio Díaz et al.
5 citations
Alimentary Pharmacology & Therapeutics
Liver Disease Diagnosis and Treatment
6.77
article

Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction–Associated Steatotic Liver Disease ( MASLD )

Egbert Madamba, Sadhu Lokanadham, Daniel Q. Huang, Luis Antonio Díaz, Mísia Joyner de Sousa Dias Monteiro, Adrian Carlos Gadano, Veeral Ajmera, Amit V. Khera, Gil F. Salles, Nathalie Carvalho Leite, Fernando Javier Barreyro, Mário Reis Álvares‐da‐Silva, Francisco Javier Idalsoaga, Mário Guimarães Pessôa, Saaket Agrawal, Juan Pablo Arab, Cláudia Alves Couto, Rohit Seth Loomba, Marco A. Arrese, Seema Singh, Kaleb Tesfai, Claudia Regina Cardoso, Cristiane Alves Villela‐Nogueira, Sebastián Marciano, Ricki Bettencourt, Cláudia P. Oliveira, Gustavo Ayares, Rafael Theodoro, Jorge Martínez Morales, Lisa Richards
article en
5 citations

Abstract

The prevalence of significant fibrosis and the effect of GRS were similar in lean and nonlean MASLD, highlighting that lean MASLD patients may have a comparable risk to overweight and obese MASLD.

Alimentary Pharmacology & TherapeuticsVol. 63(6)
Broad Institute (US), Western University (CA), Brigham and Women's Hospital (US), Pontificia Universidad Católica de Chile (CL), National University of Misiones (AR), Virginia Commonwealth University (US), London Health Sciences Centre (CA), Hospital Italiano de Buenos Aires (AR), University of California San Diego (US), Hospital de Clínicas de Porto Alegre (BR), Verve Therapeutics (United States) (US), Hospital das Clínicas da Universidade Federal de Minas Gerais (BR), Hospital Universitário Clementino Fraga Filho (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
Openalex Percentile: Top 3%
Liver Disease Diagnosis and Treatment
6.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.